Beam Therapeutics (NASDAQ:BEAM) shareholders have earned a 18% CAGR over the last three years - Simply Wall St

Beam Therapeutics (NASDAQ:BEAM) shareholders have earned a 18% CAGR over the last three years  Simply Wall St